Go Deep
Apnimed, Inc.
Apnimed, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -18,507 | 2.5 | -4.21 | 1.30 | 1,698.02 |
| Oct 2026 | -18,351 | 2.4 | -4.07 | 1.30 | 1,635.95 |
| Oct 2026 | -18,615 | 2.6 | -4.31 | 1.30 | 1,732.56 |
| Oct 2026 | -18,488 | 2.5 | -4.20 | 1.30 | 1,682.14 |
| Oct 2026 | -18,186 | 2.3 | -3.92 | 1.30 | 1,573.48 |
| Oct 2026 | -18,683 | 2.6 | -4.37 | 1.30 | 1,755.05 |
| Oct 2026 | -18,785 | 2.6 | -4.47 | 1.30 | 1,787.60 |
| Oct 2026 | -18,689 | 2.6 | -4.38 | 1.30 | 1,749.06 |
| Oct 2026 | -18,808 | 2.6 | -4.49 | 1.30 | 1,799.91 |
Apnimed, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|
| Revenue | 12,080,000.0 | 84,814,000.0 | 17,110,000.0 | 3,131,000.0 |
| Net Profit | 125,935,000.0 | 70,373,000.0 | -69,474,000.0 | -28,646,000.0 |
| EPS | 3.2 | 2.5 | -2.4 | -1.0 |
Apnimed, Inc. Revenue & Profit: Last 2 Years
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Revenue | 38,467,000.0 | 8,012,000.0 |
| Net Profit | -932,000.0 | -111,305,000.0 |
| EPS | -0.0 | -3.9 |
Apnimed, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Total Assets | 72,873,000.0 | 109,223,000.0 |
| Total Liabilities | 445,656,000.0 | 357,838,000.0 |
| Total Equity | -372,783,000.0 | -248,615,000.0 |
Owes vs Owns
Apnimed, Inc. owed $1.90 for every $1 it owned in Jun 2026, down from $3.28 in Dec 2024.
| Period | Jun 2026 | Dec 2025 | Dec 2024 |
|---|---|---|---|
| Owes vs Owns | 1.90× | 6.12× | 3.28× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Apnimed, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 57.5%Receivables 1.3%Fixed assets (tangible) 1.2%Other assets 40.0%
How it's funded — Dec 2025
Long-term debt 9.1%Other liabilities 90.4%
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Assets | ||
| Cash & short-term investments | 41.9 | 68.3 |
| Receivables | 1.0 | 1.1 |
| Inventory | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.9 | 1.2 |
| Intangible assets | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 |
| Other assets | 29.1 | 38.6 |
| Liabilities & equity | ||
| Short-term debt | 0.2 | 0.2 |
| Long-term debt | 40.6 | 0.9 |
| Payables | 1.8 | 3.6 |
| Other liabilities | 403.0 | 353.2 |
| Shareholders' equity | -372.8 | -248.6 |
| Net tangible assets | -372.8 | -248.6 |
Apnimed, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Operating Activities | -77,832,000.0 | -110,209,000.0 |
| Investing Activities | 0.0 | 151,962,000.0 |
| Financing Activities | 51,372,000.0 | 51,000.0 |